Healio2d
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Drug Store News20d
Lupin launches generic Xarelto
Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...
Monthly Prescribing Reference25d
FDA Approves First Generics of Anticoagulant Xarelto
The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...
Hosted on MSN4mon
Medicare Pays Wildly Different Prices for the Same Drug
The same is true with other popular medicines such as psoriasis treatment Otezla, blood thinner Xarelto and generic versions of the cancer drug Tykerb, known as lapatinib, which has 460 prices ...
The Financial Express18d
FDA gives nod to first generics of Xarelto to treat stroke and heart disorders
The United States Food and Drug Administration (USFDA) (Image Credits: Reuters) The United States Food and Drug Administration (USFDA) has approved the first generics of Xarelto (rivaroxaban ...
pharmaphorum5y
FDA approves Bayer/Janssen's Xarelto in new blood clot prevention use
Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA approved it to prevent blood clots in acutely ill medical patients. The drug, marketed by ...
FiercePharma24d
As Xarelto's decline picks up speed, Bayer doesn't expect pharma growth until 2027
With sales of its top-selling product, blood thinner Xarelto, tumbling because of generic competition, Bayer isn’t projecting growth for the pharma division until 2027. Bayer’s pharma sales ...
Mint18d
Trump's tariff threat takes the sheen off Lupin’s product launches
Lupin Ltd’s recent launch of generic version of Xarelto 2.5 mg is one of the several it has planned for the US market. The estimated annual sales of the product, used as an anticoagulant agent ...
Morningstar12d
Bayer's Near-Term Outlook Dominated by Generic Pressures and Crop Science Uncertainty
In the healthcare division, Bayer is seeing declines in cardiovascular drug Xarelto due to loss of exclusivity events across various territories, which is putting pressure on both revenue growth ...
Lupin launches Rivaroxaban drug in US
Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...
pharmaphorum25d
FDA approves first generics of anticoagulant Xarelto
The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2 ...